Autism Screening
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social communication skill deficits and restricted and repetitive patterns of behavior, interests, and activities that typically appear within the first 2 years of life. ASD has a prevalence of 1:36 children. [Maenner: 2023] Using screening tools for ASD in early childhood can help primary care providers detect symptoms more reliably than surveillance alone and lead to early intervention, which can improve developmental outcomes.
Key Points
Concerns despite a negative screen
Screening tools may have false negative results that can delay
diagnosis and intervention. When concerning behaviors are reported by the
caregiver or observed during a well-child visit, despite a negative autism
screen, consider referring for a formal evaluation.
Refer for behavioral therapy while awaiting a formal evaluation
Due to prolonged wait times for diagnostic testing, some Medicaid
and private insurers will cover evidence-based behavioral therapy, such as
applied behavioral analysis (ABA), for a child strongly suspected of having
autism. For children under age 3, also provide a referral to Early Intervention.
Any child with a suspected speech and/or language delay should also be referred
to audiology for a hearing evaluation.
Validation issues
Many Level 1 screening tools used in a low-risk population were
initially validated in at-risk populations or children already diagnosed with
ASD. As a result, their stated psychometric properties may not reflect the
tool’s performance in the general population. In addition, many ASD screening
tools were validated using DSM-IV (or earlier) diagnostic criteria for autism or
pervasive developmental disorders. When a screening tool has been translated
into multiple languages, validation data are frequently not available for
non-English versions.
Practice Guidelines
Hyman SL, Levy SE, Myers SM.
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder.
Pediatrics.
2020;145(1).
PubMed abstract / Full Text
Lipkin PH, Macias MM.
Promoting Optimal Development: Identifying Infants and Young Children With Developmental Disorders Through Developmental Surveillance
and Screening.
Pediatrics.
2020;145(1).
PubMed abstract
Screening Recommendations
Though the U.S. Preventive Services Task Force in 2016 found insufficient evidence to recommend screening for ASD in young children who have had no concerns of ASD raised by their parents or a clinician, the American Academy of Pediatrics (AAP) and the Council on Children with Disabilities advise the following: [Hyman: 2020] [Lipkin: 2020]
- Provide ongoing developmental surveillance at every well-child visit.
- Implement autism screening at 18 and 24 months.
- Develop a plan for referral and further evaluation of children with a positive screen or a family member or clinician with concerns.
Surveillance Tips
- At 6 months: absence of babbling, social smile, or eye contact
- At 12 months: does not respond to name
- At 14 months: does not point at objects to show interest
- At 18 months: does not pretend play
- In early childhood:
- Avoids eye contact and may want to be alone
- Has trouble understanding other people’s feelings or talking about their own feelings
- Has delayed speech and language skills
- Repeats words or phrases over and over (echolalia)
- Gives unrelated answers to questions
- Gets upset by minor changes
- Has obsessive interests
- Makes repetitive movements like flapping hands, rocking, or spinning in circles
- Has unusual reactions to the way things sound, smell, taste, look, or feel
- Loss of earlier skills like toileting, language, social or motor skills
Selecting a Screen
Level 1 screens are “universal” and developed for use in general populations regardless of pre-existing risk factors.
Level 2 screens are designed for children with increased risk for ASD (e.g., siblings of children with ASD or children referred for developmental evaluation) and are not commonly performed in a primary care setting.
Some screens are designed specifically to detect autism, while others contain cross-cutting elements that screen for autism, developmental delays, and early childhood social-emotional disorders. When selecting a screen to use in clinical practice, consider:- Availability, cost, and psychometric properties of the instrument (e.g., rate of false positives)
- Patient characteristics (e.g., language, reading ability, web access)
- How the screen will be integrated into the clinic workflow and medical records
- How and when to discuss the results with the family
- Where to refer children for additional testing and support
Level 1 Autism Screening Tools
Communication and Symbolic Behavior Scales Developmental Profile (CSBS DP)
Infant-Toddler Checklist
This focused developmental screen quantifies a child’s proficiency
in 3 subdomains: social and emotional communication, receptive and expressive
speech, and symbolic behavior. It can be used earlier than many autism-specific
screens, although it has a low positive predictive value for ASD alone.
- Format: 24-item, paper or computerized questionnaire, 5-10 minutes for parent/professional report (scored <2 minutes by medical staff)
- Age range: Functional communication age between 6 months and 24 months
- Languages: English
- Sensitivity=89% and specificity=89% for ASD or other developmental delays; however, positive predictive value of 20% for ASD alone when used as a stand-alone broadband screener. [Wetherby: 2008] [Towle: 2016] Scoring based on 10th percentiles.
Modified Checklist for Autism in Toddlers – Revised, with Follow-Up
(M-CHAT-R/F)
This well-studied, 2-step autism screen uses 20 Yes/No questions
about joint attention, pretend play, repetitive behaviors, and sensory
differences. The scoring algorithm places children in 3 risk categories, with
the intermediate category prompting standardized follow-up questions. This
revision to the M-CHAT reduced the initial screen-positive rate while increasing
ASD detection. About half of the 7% of children in the medium- or high-risk
categories were diagnosed with ASD. The majority of the remaining children were
found to have another developmental disorder or concern. M-CHAT-R/F has been
translated into many languages and contexts; although not all are validated,
their availability makes it a desirable option for many practices.
- Format: 20-item, 5-10 minutes to complete (~1 minute to score first part but may take an additional 5-10 minutes to perform a follow-up interview in the office or over the telephone for medium-risk respondents), paper and online forms, first step completed by parent/caregiver, second step (when indicated) completed by a clinician for the paper version (or by the parent in online versions in development)
- Age range: 16–30 months of age
- Languages: >50 languages in printable forms, and English and Spanish online versions. Most of these translations have not been formally validated or validation is still underway.
- Scoring: The initial step is administration of the M-CHAT-R/F to stratify into low-, medium-, and high-risk categories. For the medium-risk group (scores of 3-7 on the first part), use the follow-up tool to ask specific questions to improve specificity and determine need for referral. Refer high-risk patients (scores of ≥8 on the first part) directly for further evaluation.
- Sensitivity = 85% - sensitivity may be lower in some settings. [Carbone: 2020] Specificity = 99% [Robins: 2014]
Parent’s Observations of Social Interactions (POSI)
POSI is a component of the Survey of Well-Being of Young Children
(SWYC), encompassing screening and surveillance topics at every well-child
visit. The components may be bundled or used separately. Scoring algorithms for
each component of the SWYC can be done in Excel, manually, or via the electronic
medical record in an integrated eSWYC system. The brevity of the POSI makes it
appealing; however, a higher screen-positive rate in the primary care setting
presents challenges in determining which children to refer for formal
evaluation.
- Format: 7-item screen that is part of a set of age-specific tools, usually completed in less than 5 minutes. Asks parents to rate the consistency of behaviors (e.g., sometimes, always, never).
- Age range: 16-35 months and 31 days. The POSI is integrated into the 18-, 24-, and 30-month SWYC screens.
- Languages: English, Spanish, Khmer, Burmese, Nepali, Portuguese, Haitian-Creole, and Arabic
- Scoring: ≥3 indicates increased risk
- Sensitivity=83-93% and specificity=42-75% in a primary care setting [Hyman: 2020]
Response to a Positive Screen
Talking with Parents
Testing
When a positive screen indicates a child is at risk for ASD, timely referral for formal diagnostic evaluation is key. An evaluation using evidence-based tools, such as the Autism Diagnostic Observation Schedule (ADOS) or Childhood Autism Rating Scale (CARS), is generally required for the diagnosis. If testing for an educational diagnosis of autism is performed through the school district, review the report to see if additional testing is indicated to formalize a medical diagnosis. If unsure, contact a specialist.
Consider referral for additional evaluations, such as occupational therapy, physical therapy, genetic counseling, genetic testing, speech-language evaluation, pediatric neurology, ophthalmology, or audiology. Some developmental assessment centers provide multi-disciplinary evaluations as part of assessing the child.
Referrals
- Early Intervention
- School district-based services
- Speech-language therapy
- Occupational therapy
- Physical therapy
- Behavioral health
Care Coordination
Monitoring
Other Autism Screening Tools
Level 2 Autism Screening Tools
The ASRS has a version for preschool and older children, as well as a 15-item short version. It can be used for screening, diagnostic purposes, and monitoring treatment. [Goldstein: 2009]
The STAT is an interactive, observational screen administered by trained providers to assess key social and communicative behaviors, including imitation, play, requesting, and directing attention.
The SRS-2 includes a preschool and school-aged version and is used to distinguish the presence and severity of social impairment to differentiate among autism and other disorders. It also can be used for symptom monitoring.
The RITA-T is an interactive, observational screen administered by trained providers, designed for ages 12-36 months. [Choueiri: 2015]
Emerging Autism Screening Tools
- Format: A 10-item, <5 minutes, paper form completed by parent/caregiver
- Age range: 18-24 months
- Languages: The 10-item version is available in English, Spanish, Arabic, Chinese, German, Hungarian, Indonesian, Portuguese, Romanian, and Serbian. The Q-CHAT 25-item version is also available in French, Hebrew, Italian, Polish, Romanian, Slavic, and Swedish.
- Scoring: Uses a 5-point Likert scale - ≥3 indicates increased risk
- Sensitivity: In a validation study by Raza et al., sensitivity at 18 and 24 months was greater than 70% for detecting ASD in a high-risk cohort.
- Specificity: In the same study, inclusion of high-risk toddlers with atypical development who were not diagnosed with ASD at 36 months lowered the specificity to less than 70%, without about two-thirds of toddlers in the high-risk cohort screening falsely positive [Raza: 2019]
- In a more recent study comparing the Q-CHAT-10 to the M-CHAT-R and M-CHAT-R/F, the Q-CHAT-10 was more specific (95%) but less sensitive (34%). The study did not risk-stratify participants. The study also investigated an ordinally scored version of the Q-CHAT-10, called Q-CHAT-O, which demonstrated a sensitivity of 63% and specificity of 79%.
A short screen derived from the longer BISCUIT-Part I (62-item diagnostic instrument) based on DSM-5 criteria.
A mobile app that uses artificial intelligence and machine learning to evaluate a series of parent and clinician‐report questions. Clinical ratings of brief video segments are uploaded via smartphone to calculate level of ASD risk in general and high-risk populations. Cognoa [Megerian: 2022]
A brief teacher questionnaire based on DSM-5 ASD criteria to help clinicians and researchers screen for autism spectrum and social communication disorders in school settings. [Morales-Hidalgo: 2017]
A screening tool for social communication and sensory regulatory functions to help with early recognition of autism, performed at age 12 months. First-Year Inventory (FYI) [Reznick: 2007]
A concise, 1-step screen for autism in toddlers and young children. It shows promising psychometric properties. [Zahorodny: 2018]
Referrals and Services
Services to help evaluate children for ASD and provide developmental services during the diagnostic process may include:
Early Intervention for Children with Disabilities/Delays
(see NV providers
[30])
Federally supported and provide developmental assessments and
therapies for children ages 0-36 months at risk of developmental delays. A quality
Early Intervention Program should provide:
- Full assessment of a child's current health and developmental status
- Service coordination among providers, programs, and agencies
- Strategies to build on family concerns, priorities, and resources
- Services including occupational therapy, physical therapy, and speech-language therapy
Head Start/Early Head Start
(see NV providers
[66])
Infant/preschool services, such as Early Head Start for children
ages 0-3 years and Head Start for children ages 3-5 years, provide learning
opportunities and parent training to help children maintain or develop skills to
help them be ready to learn when they enter school.
School Districts
(see NV providers
[4])
Children ages 3 and older can be evaluated by their school
district for special education. After neuropsychological testing for special
education services, a child may obtain an educational diagnosis of autism,
meaning that the child qualifies for autism-oriented educational interventions
to increase their likelihood of success in the school setting.
The educational neuropsychological evaluation may include an Autism Diagnostic Observation Standard, 2nd Edition (ADOS-2), or the Autism Diagnostic Interview-Revised (ADI-R), both considered the “gold standard” for testing for ASD, or it may rely on less extensive evaluation tools. Because of this variability, an educational diagnosis may or may not also result in a medical diagnosis of ASD. Review the child’s neuropsychological testing thoroughly, and share this information with the autism specialist evaluating the child to see if additional testing is still warranted.
Behavioral Therapies
(see NV providers
[19])
These programs focus on improving behavioral skills for children
with identified developmental delays or behavioral conditions.
General Counseling Services
(see NV providers
[211])
This category includes all types of counselors/counseling for
children. Once on the page, find results by city or use the Search within this
Category field.
Psychiatry/Medication Management
(see NV providers
[37])
Often working with child psychologists, psychiatrists can prescribe
medications that treat underlying medical or mental health conditions. They do not
usually diagnose ASD.
Autism Programs
(see NV providers
[2])
Condition-specific clinics, such as a clinic for autism, may be
available where children can have formal testing for autism and/or have access to
specialized and multi-disciplinary care.
CSHCN Clinics
(see NV providers
[5])
Some states may have state-funded or federally funded clinics with
expertise in diagnosing or coordinating care for children with complex
conditions, including those with developmental delays.
Developmental - Behavioral Pediatrics
(see NV providers
[3])
Specialty-trained pediatricians may diagnose autism. Developmental
pediatricians provide evaluations of developmental delays and advice on
treatments.
Patient Education
A printable resource explaining autism screening in the primary care setting. Written and audio versions in English and Spanish; American Academy of Pediatrics.
Resources
Information & Support
Related Portal Content
If interested in a further list of autism screens, contact your state's Medicaid agency for other recommended tools.
-
ICD-10
Z13.41, Encounter for autism screening -
CPT
96110, Developmental screening
For Professionals
Autism Initiatives (AAP)
Autism tools, practice guidelines, CME for pediatricians, and resources to share with families; American Academy of Pediatrics.
Classification of Mental and Developmental Disorders (Zero to Three)
Introduces DC:0–5 (developmentally specific diagnostic criteria and information about mental health disorders in infants and
young children), discusses why DC:0–5 is important, and provides policy recommendations.
Birth to 5: Watch Me Thrive (HHS & DOE) ( 1007 KB)
An early care and education provider’s guide for developmental and behavioral screening. Contains developmental screening
measures for young children and information about the reliability and validity of commonly used developmental screening tools;
U.S. Department of Health and Human Services and U.S. Department of Education, 2014.
Autism Spectrum Disorder in Under 19s (NICE)
Clinical guideline for recognition, referral, and diagnosis of autism from birth up to 19 years; United Kingdom's National
Institute for Health and Care Excellence.
For Parents and Patients
Autism Spectrum Disorder: What Every Parent Needs to Know, 2nd Edition (AAP)
Reliable information about how ASD is defined and diagnosed and the most current behavioral, developmental, educational, and
medical therapies. Topics covered align with the DSM-5 updates. Paperback and eBook versions available for purchase; American
Academy of Pediatrics.
Zero to Three
A national nonprofit organization that promotes the health and development of infants and toddlers. Provides information and
resources for parents and professionals about the development, learning, behavior, and well-being of infants and toddlers.
Includes real-life video examples, articles, and FAQs.
Screening and Diagnosis of Autism Spectrum Disorder (CDC)
A brief explanation of screening and diagnosis of ASD, written for families. Spanish language version available; Centers for
Disease Control and Prevention
Autism (healthychildren.org)
Answers to questions such as: How is autism diagnosed? If autism is suspected, what next? What are early signs? How do I keep
a child with autism from wandering?
Autism Spectrum Disorder FAQ (NINDS)
Answers to common questions about ASD and a long list of other places to go for more information; National Institute of Neurologic
Disorders and Stroke.
Tools
Screening Technical Assistance and Resource (STAR)
Provides guidance with screening tool selection, implementation, and follow-up; American Academy of Pediatrics.
Caring for Children with Autism Spectrum Disorders: A Resource Toolkit for Clinicians (AAP)
Supports for health care professionals in the identification and ongoing management of children with autism; American Academy
of Pediatrics.
Services for Patients & Families in Nevada (NV)
Service Categories | # of providers* in: | NV | NW | Other states (3) (show) | | NM | RI | UT |
---|---|---|---|---|---|---|---|---|
Autism Programs | 2 | 1 | 7 | 4 | 56 | |||
Behavioral Therapies | 19 | 1 | 17 | 35 | 37 | |||
CSHCN Clinics | 5 | 2 | 4 | 13 | 5 | |||
Developmental - Behavioral Pediatrics | 3 | 1 | 2 | 12 | 9 | |||
Early Intervention for Children with Disabilities/Delays | 30 | 3 | 34 | 13 | 51 | |||
General Counseling Services | 211 | 1 | 10 | 30 | 260 | |||
Head Start/Early Head Start | 66 | 10 | 18 | 25 | ||||
Psychiatry/Medication Management | 37 | 3 | 80 | 55 | ||||
School Districts | 4 | 90 | 64 | 42 |
For services not listed above, browse our Services categories or search our database.
* number of provider listings may vary by how states categorize services, whether providers are listed by organization or individual, how services are organized in the state, and other factors; Nationwide (NW) providers are generally limited to web-based services, provider locator services, and organizations that serve children from across the nation.
Studies
SPARK National Autism Study
Studies genetic, behavioral, and medical information from hundreds of thousands of people to advance research and discovery
in autism. Information is gathered online and participants mail in a saliva sample for genetic testing. The results are provided
to the participant. Funded and led by the Simons Foundation.
Helpful Articles
Janvier YM, Harris JF, Coffield CN, Louis B, Xie M, Cidav Z, Mandell DS.
Screening for autism spectrum disorder in underserved communities: Early childcare providers as reporters.
Autism.
2016;20(3):364-73.
PubMed abstract
Findings suggest that early childcare providers can effectively screen young children for autism spectrum disorder in preschool/daycare
settings, thus improving access to early diagnosis and reducing potential healthcare disparities among underserved populations.
Zwaigenbaum L, Penner M.
Autism spectrum disorder: advances in diagnosis and evaluation.
BMJ.
2018;361:k1674.
PubMed abstract
This review describes advances in detecting early behavioral and biological markers, current options and controversies in
screening for the disorder, and best practice in its diagnostic evaluation including emerging data on innovative service models.
Siu AL, Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW, Ebell M, García FA, Gillman M, Herzstein J, Kemper AR, Krist
AH, Kurth AE, Owens DK, Phillips WR, Phipps MG, Pignone MP.
Screening for Autism Spectrum Disorder in Young Children: US Preventive Services Task Force Recommendation Statement.
JAMA.
2016;315(7):691-6.
PubMed abstract
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for
ASD in young children for whom no concerns of ASD have been raised by their parents or a clinician.
Zwaigenbaum L, Bauman ML, Fein D, Pierce K, Buie T, Davis PA, Newschaffer C, Robins DL, Wetherby A, Choueiri R, Kasari C,
Stone WL, Yirmiya N, Estes A, Hansen RL, McPartland JC, Natowicz MR, Carter A, Granpeesheh D, Mailloux Z, Smith Roley S, Wagner
S.
Early Screening of Autism Spectrum Disorder: Recommendations for Practice and Research.
Pediatrics.
2015;136 Suppl 1:S41-59.
PubMed abstract
This article reviews evidence for autism spectrum disorder (ASD) screening to promote earlier detection and diagnosis, consistent
with current American Academy of Pediatrics’ recommendations. The article identifies ASD-specific and broadband screening
tools that have been evaluated in large community samples and suggests strategies to help overcome challenges to implementing
ASD screening.
Authors & Reviewers
Author: | Claire K Turscak, MD, MS |
Reviewer: | Allison Ellzey, MD, MSEd |
2019: first version: Jennifer Goldman, MD, MRP, FAAPA; Sean Cunningham, Ph.D.R; Kathleen Campbell, MD, MHScR; Paul Carbone, MDR |
Page Bibliography
Barbaro J, Dissanayake C.
Autism spectrum disorders in infancy and toddlerhood: a review of the evidence on early signs, early identification tools,
and early diagnosis.
J Dev Behav Pediatr.
2009;30(5):447-59.
PubMed abstract
It is recommended that future prospective Autism Spectrum Disorders (ASD) studies monitor behavior repeatedly over time, thereby
increasing the opportunity to identify early manifestations of ASD and facilitating the charting of subtle behavioral changes
that occur in the development of infants and toddlers with ASD.
Carbone PS, Campbell K, Wilkes J, Stoddard GJ, Huynh K, Young PC, Gabrielsen TP.
Primary Care Autism Screening and Later Autism Diagnosis.
Pediatrics.
2020;146(2).
PubMed abstract / Full Text
Choueiri R, Wagner S.
A New Interactive Screening Test for Autism Spectrum Disorders in Toddlers.
J Pediatr.
2015;167(2):460-6.
PubMed abstract
Discusses the validation of the Rapid Interactive Screening Test for Autism in Toddlers (RITA-T), a level 2 interactive screening
tool for improving the early identification of ASD in toddlers in general pediatric and early intervention settings.
Goldstein, S., & Naglieri, J.A.
ASRS: Autism Spectrum Rating Scales.
Toronto, Ontario, Canada: Multi-Health Systems;
2009.
Hyman SL, Levy SE, Myers SM.
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder.
Pediatrics.
2020;145(1).
PubMed abstract / Full Text
Comprehensive clinical report addressing the prevalence, clinical symptoms, screening and diagnosis, etiologic evaluation,
and interventions for children with autism spectrum disorder.
Janvier YM, Harris JF, Coffield CN, Louis B, Xie M, Cidav Z, Mandell DS.
Screening for autism spectrum disorder in underserved communities: Early childcare providers as reporters.
Autism.
2016;20(3):364-73.
PubMed abstract
Findings suggest that early childcare providers can effectively screen young children for autism spectrum disorder in preschool/daycare
settings, thus improving access to early diagnosis and reducing potential healthcare disparities among underserved populations.
Lipkin PH, Macias MM.
Promoting Optimal Development: Identifying Infants and Young Children With Developmental Disorders Through Developmental Surveillance
and Screening.
Pediatrics.
2020;145(1).
PubMed abstract
Includes the developmental surveillance algorithm and a detailed description of each step, including follow-up assessment
and implementation of developmental screening at each preventive care visit through the first 5 years of life.
Maenner MJ, Warren Z, Williams AR, Amoakohene E, Bakian AV, Bilder DA, Durkin MS, Fitzgerald RT, Furnier SM, Hughes MM, Ladd-Acosta
CM, McArthur D, Pas ET, Salinas A, Vehorn A, Williams S, Esler A, Grzybowski A, Hall-Lande J, Nguyen RHN, Pierce K, Zahorodny
W, Hudson A, Hallas L, Mancilla KC, Patrick M, Shenouda J, Sidwell K, DiRienzo M, Gutierrez J, Spivey MH, Lopez M, Pettygrove
S, Schwenk YD, Washington A, Shaw KA.
Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities
Monitoring Network, 11 Sites, United States, 2020.
MMWR Surveill Summ.
2023;72(2):1-14.
PubMed abstract / Full Text
Megerian JT, Dey S, Melmed RD, Coury DL, Lerner M, Nicholls CJ, Sohl K, Rouhbakhsh R, Narasimhan A, Romain J, Golla S, Shareef
S, Ostrovsky A, Shannon J, Kraft C, Liu-Mayo S, Abbas H, Gal-Szabo DE, Wall DP, Taraman S.
Evaluation of an artificial intelligence-based medical device for diagnosis of autism spectrum disorder.
NPJ Digit Med.
2022;5(1):57.
PubMed abstract / Full Text
Morales-Hidalgo P, Hernández-Martínez C, Voltas N, Canals J.
EDUTEA: A DSM-5 teacher screening questionnaire for autism spectrum disorder and social pragmatic communication disorder.
Int J Clin Health Psychol.
2017;17(3):269-281.
PubMed abstract / Full Text
This study examines the validation of the EDUTEA questionnaire which aims to provide clinicians and researchers with a brief
tool that can be used to screen autism spectrum disorders and social communication disorders in school settings.
Raza S, Zwaigenbaum L, Sacrey LR, Bryson S, Brian J, Smith IM, Reid K, Roberts W, Szatmari P, Vaillancourt T, Roncadin C,
Garon N.
Brief Report: Evaluation of the Short Quantitative Checklist for Autism in Toddlers (Q-CHAT-10) as a Brief Screen for Autism
Spectrum Disorder in a High-Risk Sibling Cohort.
J Autism Dev Disord.
2019;49(5):2210-2218.
PubMed abstract
Reznick JS, Baranek GT, Reavis S, Watson LR, Crais ER.
A parent-report instrument for identifying one-year-olds at risk for an eventual diagnosis of autism: the first year inventory.
J Autism Dev Disord.
2007;37(9):1691-710.
PubMed abstract
This article reviews a parent-report instrument, the First Year Inventory (FYI), which was developed to assess behaviors in
12-month-old infants that suggest risk for an eventual diagnosis of autism.
Robins DL, Casagrande K, Barton M, Chen CM, Dumont-Mathieu T, Fein D.
Validation of the modified checklist for Autism in toddlers, revised with follow-up (M-CHAT-R/F).
Pediatrics.
2014;133(1):37-45.
PubMed abstract / Full Text
This study validated the Modified Checklist for Autism in Toddlers, Revised with Follow-up (M-CHAT-R/F), a screening tool
for low-risk toddlers, and demonstrated improved utility compared with the original M-CHAT.
Siu AL, Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW, Ebell M, García FA, Gillman M, Herzstein J, Kemper AR, Krist
AH, Kurth AE, Owens DK, Phillips WR, Phipps MG, Pignone MP.
Screening for Autism Spectrum Disorder in Young Children: US Preventive Services Task Force Recommendation Statement.
JAMA.
2016;315(7):691-6.
PubMed abstract
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for
ASD in young children for whom no concerns of ASD have been raised by their parents or a clinician.
Towle PO, Patrick PA.
Autism Spectrum Disorder Screening Instruments for Very Young Children: A Systematic Review.
Autism Res Treat.
2016;2016:4624829.
PubMed abstract / Full Text
This study investigates the potential and risks of using autism screening instruments for young children up to 18 months.
Tran AT, Del Rosario M, Nosco E, Li Y, Senturk D, Mcdonald NM, Wilson RB, Dapretto M, Jeste SS.
Early concerns in parents of infants at risk for autism.
Dev Med Child Neurol.
2021;63(12):1410-1416.
PubMed abstract / Full Text
Wetherby AM, Brosnan-Maddox S, Peace V, Newton L.
Validation of the Infant-Toddler Checklist as a broadband screener for autism spectrum disorders from 9 to 24 months of age.
Autism.
2008;12(5):487-511.
PubMed abstract / Full Text
This article provides a brief review of research on the accuracy of screeners for children with ASD that have been administered
to general pediatric samples and the results of a population-based study with a broadband screener to detect children with
communication delays including children with ASD.
Zahorodny W, Shenouda J, Mehta U, Yee E, Garcia P, Rajan M, Goldfarb M.
Preliminary Evaluation of a Brief Autism Screener for Young Children.
J Dev Behav Pediatr.
2018;39(3):183-191.
PubMed abstract / Full Text
This study examines the validity of a parent report-based Level 1 (low risk, general population) screen of toddler psychological
development. Findings suggest that the PDQ-1 may be a useful supplement to developmental surveillance of autism.
Zwaigenbaum L, Bauman ML, Fein D, Pierce K, Buie T, Davis PA, Newschaffer C, Robins DL, Wetherby A, Choueiri R, Kasari C,
Stone WL, Yirmiya N, Estes A, Hansen RL, McPartland JC, Natowicz MR, Carter A, Granpeesheh D, Mailloux Z, Smith Roley S, Wagner
S.
Early Screening of Autism Spectrum Disorder: Recommendations for Practice and Research.
Pediatrics.
2015;136 Suppl 1:S41-59.
PubMed abstract
This article reviews evidence for autism spectrum disorder (ASD) screening to promote earlier detection and diagnosis, consistent
with current American Academy of Pediatrics’ recommendations. The article identifies ASD-specific and broadband screening
tools that have been evaluated in large community samples and suggests strategies to help overcome challenges to implementing
ASD screening.
Zwaigenbaum L, Penner M.
Autism spectrum disorder: advances in diagnosis and evaluation.
BMJ.
2018;361:k1674.
PubMed abstract
This review describes advances in detecting early behavioral and biological markers, current options and controversies in
screening for the disorder, and best practice in its diagnostic evaluation including emerging data on innovative service models.